From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Redemptions Watch: disaster strikes Neil Woodford (yet again) as Neil fails to do his homework - he should have listened to me!

By Nigel Somerville | Thursday 8 August 2019


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Oh dear, oh dear, oh dear. So the Muddy Waters report was indeed about AIM-listed Burford Capital which duly crashed by 46% yesterday, to add to the 19% drop on Tuesday, and Neil Woodford’s second biggest stock pick is…er….no longer his second biggest investment. I rather doubt it is in his top ten now. The press, as predicted, has been baying for blood and the queues of gated Woodford Equity Income Fund investors looking to get their money back before any more of it just disappears into thin air will be lengthening. So let’s take a look at the effect of the Burford collapse on the Woodford empire.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:


Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 07:50:22